NRCのチャート
NRCの企業情報
symbol | NRC |
---|---|
会社名 | National Research Corp (ナショナル・リサ―チ) |
分野(sector) | Health Care ヘルスケア |
産業(industry) | Biotechnology: Commercial Physical_Biological Resarch |
業種 | 事業サポ―トサ―ビス 医療関連(Health Care) |
概要 | 事業概要 ナショナル・リサーチ(National Research Corporation)はNRCヘルスとして事業を行い、医療提供者、支払人および他の医療機関向けに分析と洞察の提供に従事する。同社はエクスペリエンス、ガバナンス・インスティテュート、マーケット・インサイト、透明性、ナショナル・リサーチ・コーポレーション・カナダおよびコネクトの6つのセグメントを通じて事業を行う。同社のサブスクリプションベースのソリューションのポートフォリオは患者の経験と満足度、地域住民の健康リスク、労働力の関与、地域社会の認識、医師の関与などの構成要素に関連する情報や分析をヘルスケア組織と支払人に提供する。NRCヘルスはヘルスケアサービスを提供する。同社の顧客は、統合保健システム、家庭の健康、長期ケア、ホスピスなどの急性期後のプロバイダー、支払人の組織を含む。NRCヘルスのソリューションのポートフォリオは、ヘルスケア企業に役立つように設計される。 ナショナル・リサ―チは米国の医療関連サ―ビス会社。医療提供者や医療機関における患者、従業員、顧客保持率や患者との関わりを分析する。救急病院、および在宅医療、長期介護、ホスピスなどの急性期後の施設向けに、グロ―スソリュ―ション、リテンションソリュ―ション、エンゲ―ジメントソリュ―ション、ソ―トリ―ダ―シップソリュ―ションを提供する。 NRC Health is the leading provider of in-depth customer insights in healthcare. |
本社所在地 | 1245 Q Street Lincoln NE 68508 USA |
代表者氏名 | Steven D. Jackson スティーブンD.ジャクソン |
代表者役職名 | President Chief Operating Officer 社長兼最高執行責任者(COO) |
電話番号 | +1 402-475-2525 |
設立年月日 | 1981年 |
市場名 | NASDAQ National Market System |
ipoyear | ―年 |
従業員数 | 458人 |
url | www.nationalresearch.com |
nasdaq_url | https://www.nasdaq.com/symbol/nrc |
adr_tso | ― |
EBITDA | EBITDA(百万ドル) 37.44700 |
終値(lastsale) | 36.5601 |
時価総額(marketcap) | 904459692.3783 |
時価総額 | 時価総額(百万ドル) 915.34230 |
売上高 | 売上高(百万ドル) 117.88300 |
企業価値(EV) | 企業価値(EV)(百万ドル) 948.33530 |
当期純利益 | 当期純利益(百万ドル) 23.89000 |
決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 National Research Corporation revenues increased 1% to $59M. Net income applicable to common stockholders increased 25% to $15.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other net increase from $36K to $465K (income) Interest income increase of 86% to $54K (income). |
NRCのテクニカル分析
NRCのニュース
Vogtle 3 & 4 nuclear units take significant steps toward operations 2023/04/01 11:46:00 Kwhen Finance
National Research Stock: Reiterate Buy After Q4, FY22'' Numbers (NASDAQ:NRC) 2023/02/17 15:57:05 Seeking Alpha
National Research Corporation came in with a strong set of Q4 and full-year numbers. Click here to read more about NRC stock analysis.
National Research Corporation (NRC) Q4 2022 Earnings Call Transcript 2023/02/15 17:39:07 Seeking Alpha
National Research Corporation (NASDAQ:NASDAQ:NRC) Q4 2022 Earnings Conference Call February 15, 2023 11:00 AM ETCompany ParticipantsKevin Karas - CFOLinda Stacy - VP, FinanceConference Call…
National Research: Q4 Earnings Snapshot 2023/02/14 23:06:29 WTOP
LINCOLN, Neb. (AP) — LINCOLN, Neb. (AP) — National Research Corp. (NRC) on Tuesday reported fourth-quarter earnings of $6.6 million.…
National Research GAAP EPS of $0.27, revenue of $38.14M 2023/02/14 22:04:33 Seeking Alpha
National Research press release (NASDAQ:NRC): Q4 GAAP EPS of $0.27.Revenue of $38.14M (-0.4% Y/Y).
National Research Corporation slashes dividend to $0.12 2022/11/11 22:05:19 Seeking Alpha
National Research Corporation (NRC) declares $0.12/share quarterly dividend, 50.0% decrease from prior dividend of $0.24.Forward yield 1.22%Payable Jan 13; for shareholders of record Dec.
National Research Corporation (NRC) Q3 2022 Results - Earnings Call Transcript 2022/11/06 01:46:06 Seeking Alpha
National Research Corporation (NASDAQ:NASDAQ:NRC) Q3 2022 Earnings Conference Call November 03, 2022 10:00 AM ET Company Participants Linda Stacy - VP, Finance Kevin Karas - Chief Financial…
National Research Corporation Announces Third Quarter 2022 Results 2022/11/01 21:00:00 GlobeNewswire
LINCOLN, Neb., Nov. 01, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2022.
Massive Insider Trade At National Research 2022/10/25 14:16:29 Benzinga
Amandla MK Trust , 10% Owner at National Research (NASDAQ: NRC ), reported a large insider sell on October 24, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Trust sold 24,444 shares of National Research . The total transaction amounted to $992,127. National Research shares are trading up 0.29% at $40.83 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to … Full story available on Benzinga.com
National Research Corporation to Broadcast its 2022 Third Quarter Conference Call Live on the Internet 2022/10/19 18:49:00 Wallstreet:Online
Lincoln, Nebraska, Oct. 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 third quarter earnings conference call on Wednesday, November 2, 2022. The Company’s results for the 2022 third quarter will be released after the close of the market on Tuesday, November 1, 2022. The live broadcast
National Research Corp.: Market Is Discounting These Factors (NASDAQ:NRC) 2022/09/18 12:57:21 Seeking Alpha
National Research Corp. is a contrarian buy for those seeking to catch shares at discounted prices. See why I rate NRC stock a buy with $64 price target.
National Research declares $0.24 dividend 2022/08/23 21:01:27 Seeking Alpha
National Research (NASDAQ:NRC) declares $0.24/share quarterly dividend, in line with previous.Forward yield 2.69%Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept.
National Research Corporation''s (NRC) CEO Michael Hays on Q2 2022 Results - Earnings Call Transcript 2022/08/06 05:40:07 Seeking Alpha
National Research Corporation (NASDAQ:NASDAQ:NRC) Q2 2022 Earnings Conference Call August 03, 2022, 11:00 AM ET Company Participants Michael Hays - Founder and Chief Executive Officer Kevin…